siRNA, Anti-ATP6V1E1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo-modified(CAT#: SIRGT01352WQ-2OMe)

The product SIRGT01352WQ-2OMe is a type of small interfering RNA (siRNA) that targets ATP6V1E1 gene and regulates the expression of gene. The siRNA interferes with the expression of ATP6V1E1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001039366.1; NM_001039367.1; NM_001696.3
Alternative Names ARCL2C; ATP6E; ATP6E2; ATP6V1E; P31; Vma4
Related Diseases Cutis Laxa
Purification HPLC
Target Gene
Gene ID 529
Uniprot ID P36543
Sub Cat Target Species Modification Scale  
SIRGT02352WQ-2F ATP6V1E1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT03352WQ-2MOE ATP6V1E1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT04352WQ-LNA ATP6V1E1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT01352WQ-RB ATP6V1E1 Human Ribo-modified Inquiry

Related Products